初诊多发性骨髓瘤的临床试验
总计3466个结果
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.主动,不招人
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLC尚未招聘
-
Medical College of Wisconsin招聘中难治性多发性骨髓瘤 | 复发性多发性骨髓瘤美国
-
Thomas Martin, MDUniversity of California, Davis; Actavis Inc.; Eugia Pharma Specialities Limited主动,不招人
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.终止
-
Genentech, Inc.完全的
-
Tulane University School of MedicineKaryopharm Therapeutics Inc撤销难治性多发性骨髓瘤 | 复发性多发性骨髓瘤
-
Zhejiang UniversityHangzhou Cheetah Cell Therapeutics Co., Ltd招聘中
-
920th Hospital of Joint Logistics Support Force...招聘中
-
University of NebraskaM.D. Anderson Cancer Center终止
-
Oncopeptides AB终止复发性多发性骨髓瘤 | 复发难治性多发性骨髓瘤塞尔维亚, 希腊, 俄罗斯联邦, 捷克语, 保加利亚, 乔治亚州, 挪威, 波兰, 西班牙, 乌克兰, 德国
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du Myelome主动,不招人
-
Cogent Biosciences, Inc.Seagen Inc.终止
-
CelgeneCelgene Corporation完全的
-
Pfizer主动,不招人多发性骨髓瘤 | 难治性多发性骨髓瘤 | 骨髓瘤 | 复发性多发性骨髓瘤 | 埃拉那他单抗 | PF-06863135 | BCMA | 双特异性 | 双特异性抗体 | BCMA-CD3双特异性 | 磁铁MM-8中国
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)尚未招聘难治性多发性骨髓瘤 | 复发性多发性骨髓瘤
-
Elvira UmyarovaSanofi招聘中
-
University of WashingtonGenzyme, a Sanofi Company招聘中
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLC撤销
-
National Cancer Institute (NCI)主动,不招人
-
Peter MacCallum Cancer Centre, Australia未知多发性骨髓瘤 | 骨髓增生异常综合症 | 急性髓性白血病澳大利亚
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian Health终止
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.未知
-
Abdullah Khan招聘中
-
Mayo ClinicNational Cancer Institute (NCI)招聘中
-
National Cancer Institute (NCI)完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.招聘中
-
National Cancer Institute (NCI)完全的
-
Liling ZhangCSPC Ouyi Pharmaceutical Co., Ltd.招聘中